Analysis of real world FRα testing in ovarian, fallopian tube, and primary peritoneal cancers
Preliminary findings from this study were previously presented in poster format at the Society of Gynecologic Oncology 2024 Annual Metting. We confirm that the submission complies with the journal requirements.
Authors
- Eric A. Severson (ORCID: https://orcid.org/0000-0003-4394-2412)
- J. Klein
- Zachary D. Wallen (ORCID: https://orcid.org/0000-0002-2278-7348)
- Catherine Watson (ORCID: https://orcid.org/0000-0002-4200-6502)
- Elizabeth Lyon
- Kari Lassen Ring (ORCID: https://orcid.org/0000-0001-5888-3713)
- Rebecca A. Previs (ORCID: https://orcid.org/0000-0001-8087-9120)
- Brian Caveney
- Shakti Ramkissoon
- Heidi Ko (ORCID: https://orcid.org/0000-0002-7247-9175)
- Kyle C. Strickland (ORCID: https://orcid.org/0000-0003-1636-5277)
- Michelle Green (ORCID: https://orcid.org/0000-0002-6055-4342)
- Michael Biorn
- Maureen Cooper
- Jennifer Armetta
- Rennie Quarles
Institutions
- LabCorp (United States) (US)
- Duke Medical Center (US)
- Roper St. Francis Healthcare (US)
- Wake Forest University (US)
- University of Virginia (US)
Publication Details
- Journal
- Gynecologic Oncology
- Published
- 2024-12-03
- DOI
- https://doi.org/10.1016/j.ygyno.2024.11.010
- Citations
- 12
- Primary Topic
- Ovarian cancer diagnosis and treatment
- Type
- article
- Field-Weighted Citation Impact
- 6.44